Sitagliptin/Metformin Sandoz 50/500 sitagliptin (as hydrochloride monohydrate)/metformin hydrochloride 50 mg/500 mg film coated tablet blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

sitagliptin/metformin sandoz 50/500 sitagliptin (as hydrochloride monohydrate)/metformin hydrochloride 50 mg/500 mg film coated tablet blister pack

sandoz pty ltd - sitagliptin hydrochloride monohydrate, quantity: 56.69 mg (equivalent: sitagliptin, qty 50 mg); metformin hydrochloride, quantity: 500 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; triethyl citrate; hyprolose; povidone; hypromellose; purified talc; titanium dioxide; microcrystalline cellulose; sodium lauryl sulfate; sodium stearylfumarate; iron oxide red - sitagliptin/metformin sandoz is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.

Vildagliptin/Metformin Adair 50 mg/ 1000 mg film-coated tablets Malta - inglés - Medicines Authority

vildagliptin/metformin adair 50 mg/ 1000 mg film-coated tablets

galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - vildagliptin, metformin hydrochloride - film-coated tablet - vildagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes

Vildagliptin/Metformin +pharma 50mg/850mg film-coated tablets Malta - inglés - Medicines Authority

vildagliptin/metformin +pharma 50mg/850mg film-coated tablets

+pharma arzneimittel gmbh hafnerstrasse 211 8054 graz , austria - film-coated tablet - vildagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

Vildagliptin/Metformin Auxilto 50 mg/850 mg film-coated tablets Malta - inglés - Medicines Authority

vildagliptin/metformin auxilto 50 mg/850 mg film-coated tablets

auxilto healthcare s.r.o. bucharova 2657/12, stodulky 158 00 praha 5 , czech republic - film-coated tablet - vildagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

Vildagliptin/Metformin Auxilto 50 mg/1000 mg film-coated tablets Malta - inglés - Medicines Authority

vildagliptin/metformin auxilto 50 mg/1000 mg film-coated tablets

auxilto healthcare s.r.o. bucharova 2657/12, stodulky 158 00 praha 5 , czech republic - film-coated tablet - vildagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes

Vildagliptin/Metformin Diagonalis 50 mg/850 mg film-coated tablets Malta - inglés - Medicines Authority

vildagliptin/metformin diagonalis 50 mg/850 mg film-coated tablets

galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - film-coated tablet - vildagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

Combodiab 50 mg/850 mg film-coated tablets Malta - inglés - Medicines Authority

combodiab 50 mg/850 mg film-coated tablets

galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

Combodiab 50 mg/1000 mg film-coated tablets Malta - inglés - Medicines Authority

combodiab 50 mg/1000 mg film-coated tablets

galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - sitagliptin, metformin hydrochloride - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes

JARDIAMET 12.5 mg / 1000 mg empagliflozin/metformin hydrochloride 12.5mg/1000mg film coated tablet blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

jardiamet 12.5 mg / 1000 mg empagliflozin/metformin hydrochloride 12.5mg/1000mg film coated tablet blister pack

boehringer ingelheim pty ltd - empagliflozin, quantity: 12.5 mg; metformin hydrochloride, quantity: 1000 mg - tablet, film coated - excipient ingredients: maize starch; copovidone; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide red; iron oxide black; macrogol 400 - jardiamet is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin is appropriate (see sections 4.2 dose and method of administration and 5.1 pharmacodynamic properties - clinical trials).,empagliflozin is indicated in adults with type 2 diabetes mellitus and established cardiovascular disease to reduce the risk of cardiovascular death (see section 5.1 pharmacodynamic properties - clinical trials).,to prevent cardiovascular deaths, empagliflozin should be used in conjunction with other measures to reduce cardiovascular risk in line with the current standard of care.

JARDIAMET 12.5 mg / 850 mg empagliflozin/metformin hydrochloride 12.5mg/850mg film coated tablet blister pack Australia - inglés - Department of Health (Therapeutic Goods Administration)

jardiamet 12.5 mg / 850 mg empagliflozin/metformin hydrochloride 12.5mg/850mg film coated tablet blister pack

boehringer ingelheim pty ltd - empagliflozin, quantity: 12.5 mg; metformin hydrochloride, quantity: 850 mg - tablet, film coated - excipient ingredients: maize starch; copovidone; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide red; iron oxide black; macrogol 400 - jardiamet is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin is appropriate (see sections 4.2 dose and method of administration and 5.1 pharmacodynamic properties - clinical trials).,empagliflozin is indicated in adults with type 2 diabetes mellitus and established cardiovascular disease to reduce the risk of cardiovascular death (see section 5.1 pharmacodynamic properties - clinical trials).,to prevent cardiovascular deaths, empagliflozin should be used in conjunction with other measures to reduce cardiovascular risk in line with the current standard of care.